ACTRN12611000999932已完成4 期
Efficacy and safety of artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in West Sumba District, East Nusatenggara Province, Indonesia
Malaria sub-directorate, Directorate General of Disease control and Environmental Sanitation0 个研究点目标入组 100 人开始时间: 2011年9月20日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 3 Years 至 65 Years(—)
- 性别
- All
入选标准
- •*age between 3 to 65 years old excluding minor female aged 12-17 years; *mono-infection with P. falciparum detected by microscopy. *presence of P. falciparum malaria asexual 500-200000/ microliter; *presence of axillary equal to or more than 37.5 degrees centigrade or history of fever during the past 48 h; *ability to swallow oral medication; *ability and willingness to comply with the study protocol for the duration of the study and to comply with the study visit schedule; and *informed consent from the patient or from a parent or guardian in the case of children.
排除标准
- •*presence of general danger signs in children aged under 5 years or signs of severe falciparum malaria according to the definitions of World Health Organization (WHO); *mixed or mono-infection with another Plasmodium species detected by microscopy; *presence of severe malnutrition (defined as a child whose growth standard is below 3 z-score, has symmetrical oedema involving at least the feet or has a mid-upper arm circumference below 110 mm); *presence of febrile conditions due to diseases other than malaria (e.g. measles, acute lower respiratory tract infection, severe diarrhoea with dehydration) or other known underlying chronic or severe diseases (e.g. cardiac, renal and hepatic diseases, Human Immuno Deficiency Virus /Auto Immune Deficiency Syndrome(HIV/AIDS); *regular medication, which may interfere with antimalarial pharmacokinetics; *history of hypersensitivity reactions or contraindications to any of the medicine(s) being tested or used as alternative treatment(s); * a positive pregnancy test * unable to or unwilling to take contraceptives
研究者
相似试验
尚未招募
不适用
Efficacy and safety of artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Kobeni (province of Hodh El Gharbi) and Timbedra (province of Echargui), MauritaniaACTRN12613000396729Ministry of Health Mauritania120
尚未招募
4 期
Efficacy and safety of Artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in EritreaInfection - Studies of infection and infectious agentsMalariaACTRN12619000859189Ministry of Health of Eritrea704
尚未招募
4 期
Efficacy and safety of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum in health units of the Agua Grande and Lobata districts of the Sao Tome Island, Sao Tome and PrincipeInfection - Studies of infection and infectious agentsMalariaACTRN12616001609448Ministry of Health of Sao Tome and Principe176
已完成
4 期
Efficacy and safety of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Keur Soce, district of Ndoffane and Guediawaye, district of Guediawaye, Senegal.MalariaACTRN12610001023044Ministry of Health and Prevention of Senegal240
尚未招募
4 期
Safety and efficacy of artesunate-amodiaquine for the treatment of uncomplicated malaria in BurundiMalariaPACTR201905610589889Ministere de la Sante Publique352
